Similar articles

• Vaccines for neglected, emerging and re-emerging diseases.

  Madhav A, Mehrotra T, Sinha P, Mutreja A. Madhav A, et al. Semin Immunol. 2020 Aug;50:101423. doi: 10.1016/j.smim.2020.101423. Epub 2020 Nov 26. Semin Immunol. 2020. PMID: 33250352 Review.
• [Immunological research of COVID-19 and emerging infectious diseases].

  Cao XT. Cao XT. Zhonghua Yi Xue Za Zhi. 2021 Jan 5;101(1):1-6. doi: 10.3760/cma.j.cn112137-20201211-03336. Zhonghua Yi Xue Za Zhi. 2021. PMID: 33423443 Chinese.
• Vaccines as remedy for antimicrobial resistance and emerging infections.

  Troisi M, Andreano E, Sala C, Kabanova A, Rappuoli R. Troisi M, et al. Curr Opin Immunol. 2020 Aug;65:102-106. doi: 10.1016/j.coi.2020.09.003. Epub 2020 Oct 23. Curr Opin Immunol. 2020. PMID: 33289646 Review.
• Elimination could be the optimal response strategy for covid-19 and other emerging pandemic diseases.

  Baker MG, Wilson N, Blakely T. Baker MG, et al. BMJ. 2020 Dec 22;371:m4907. doi: 10.1136/bmj.m4907. BMJ. 2020. PMID: 33561814 No abstract available.
• COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.

  Meo SA, Bukhari IA, Akram J, Meo AS, Klonoff DC. Meo SA, et al. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877. Eur Rev Med Pharmacol Sci. 2021. PMID: 33629336 Review.